Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
JMO.....but I think LPC were wanting more shares of Nuvilex....because nvlx was the one delaying....otherwise they would not have to put an extension on it...nvlx will sell more shares to LPC as part of the 25M funding that is left...they will need it to finish 2b trial...but fast track approval after 2b is a real possibility with Dr. Hoff on board...his connection to the FDA especially in cancer and Pancreatic cancer for that matter in unmatched...
bull
Nuvilex will rise during the trials like all bio's and pharma do...they will announce milestones during the 2b trial..
bull
Nuvilex might get bought out before approval...good example of pharma looking for small bio acquisitions and partnering is this...
J&J teams with Scripps on a new Big Pharma/biotech spinoff matchmaking effort
Scripps' two big research outfits in California and Florida have allied themselves with the J&J ($JNJ) Innovation Center in Menlo Park, CA, on an effort designed to take some of their early-stage breakthroughs and spin off new development programs, looking to kick-start a few biotech startups and Big Pharma match-ups along the way.
Scripps' big initiative here--dubbed Scripps Advance--is tailor-made to fit into a new trend in biotech. A group of venture operations have been seeding new biotechs and partnering up with pharma companies scouting for projects they can option and later pick up and push through the clinic, provided they can get past the critical proof-of-concept stage. J&J--which has been working hard at forging close ties to research organizations like Scripps--set up a global network of deal-making centers to hunt up new technologies. And it can finance new companies with the most promising technology.
"We want to work in a scout and matchmaking capability with Scripps Advance and then potentially those projects that are of interest. We would consider providing seed funding to found early-stage drug discovery companies," J&J's Thorsten Melcher told GEN.
Scripps Advance didn't wait for the announcement today to begin work. The dealmaking arm of the research institutions says it worked with the team at Atlas Venture to launch Padlock Therapeutics to hunt down new therapies targeting the protein arginine deiminases, which it describes as a new class of enzymes that can play a role in autoimmunity and epigenetics.
Padlock's technology was developed in the laboratories of TSRI investigators Paul Thompson and Kerri Mowen, in collaboration with Scripps Florida's high-throughput screening facility.
Other venture groups will be courted to help finance new companies, setting up portfolios that can be sold on to Big Pharma collaborators.
bull
if you own any other stocks ....just look at them....market is in a correction....and bio's and tech got hit big by wall street...and small and micro caps like Nuvilex is going to feel it when it is risk off like it is right now...this happens every single year..no different...bio's and tech took the market to the new highs and the sell off of bio's and tech sector when they get overbought has taken it back down....google the bio and tech sell off and read...many pages ...Nuvilex is fine...it has nothing to do with the company or stock....
bull
there you go an actual address that you can jump in your little car and go check out....
location of the facility is at 28030 Hwy 74, Lake Elsinore, CA 92570. It houses an office, a working garage, along with the additional space needed for storage of biodiesel equipment.
It has nothing to do with the news Nuvilex is putting out....it has EVERYTHING to do with the Biotech and Tech sell off....it all started with a letter to GILD from lawmakers...." The letter basically questions Gilead’s pricing of its recently approved hepatitis C virus (HCV) treatment, Sovaldi. The $84k price tag for a 12-week treatment period is considered too expensive and has come under heavy criticism. "
This triggered a sell off of both sectors that have seen nothing but up in the last 2 years....It's a correction in both sectors of runaway stocks...that's all...it will correct itself and then come back...
all my bio's are down....
bull
Fallbrook is 15 miles from Temecula...and he is still a broker...your comments on this is getting more ridiculous by the minute...which is about how often you post
yeah and you were pumping in the beginning
market corrections are usually a great op....this happens every year....wall street crap...last few years summer has been great on my bio's....2 of them doubled last summer.....and bio's got hit recently by wall street wanting to drop the pps on them...
when the market gets over the profit taking...Nuvilex will be back up with a vengeance....Feb. was an all time high for the market...hence the sell off starting in March...actually NVLX has held up well for a micro cap at this pps...
bull
Bio's can get a 5 yr extension and they will be adding patents to their family of patents that they already have...they don't have just one patent...just like any other company....unless someone here knows exactly what they have in the family of patents and knows all the dates and the info ...it is all speculation and many years down the road...
and hotstocked is just another penny site...I don't follow them...I chart my own and go by a stock's individual chart and behavior
bull
Chart looks good building a support base here 3 cents higher than the last one.....floor is moving up....
bull
Pancreatic Cancer Research Team (PCRT) is a big deal and we have not talked about much
the fact that: their mission is to organize and accelerate new agents for the treatment of pancreatic cancer
the fact that: they have 65 Oncology Clinicians, Surgeons and Researchers who are member-investigators
the fact that: the 65 represent 45 clinical research sites
the fact that: they have lab and clinical researchers in the U.S. and EU
the fact that: they share the passion to bring new advances to patients with pancreatic cancer as rapidly as possible
the fact that: they are the the only coordinated effort in the world dedicated to rapidly translating research discoveries into new treatments and supportive care for pancreatic cancer patients exclusively
the fact that: they are an affiliate of TD2
the fact that: Nuvilex has access to PCRT and that it will facilitate development
Faster Patient Enrollment (site enrollment that is nearly three times the national average)
Efficient Site Start Up (on average, the overwhelming majority of PCRT sites can be up and running within 12 to 14 weeks)
Experts to provide feedback and guidance for your data and trial design
bull
what I don't get is all of this over and over for a measly $1,000 loss...
thanks for the post wendy
bull
I see...I post to mike and you answer....you guys must be one in the same.....
make sure you come back one year from now so everyone on here can give it to you like you are giving it to them...one thing worse than short sellers to a stock is a bitter investor...
you mean his old office don't you since he has had an office in there for a long time....you guys just make it up as you go....
septmike09...I won't ask u how old u are or how long u have invested...it goes more to how long you have been investing....I will just tell u that we have all been there before and I saw in you what you felt and what you were doing wrong....don't take your frustrations on other investors...and words do hurt...that is the internet now....take responsibility for them...I guess I am showing my age here....
bull
look this has happened to all of us....but just remember this post of mine ...the stock will come back ...and the ones on the mb that preyed on you and used you because you feel like you made a mistake on this stock will be your lesson...the best lesson u learn is to lose money....someone close to me told me that and I took it to heart....and do very well now...and I am still long in XTRM....it got hit and it will come back...it is under the radar....my advice if u want to invest is go find a big cap....but u don't make the money u do here and get out the calculator and figure the shs....but if u do not have the stomach for the micro caps...many people don't....good luck
bull
thank you some sanity
bull
and wrong answer ...u are not being honest to the mb....u already told us u sold for a loss...now u are bitter ...I have seen this crap so many times before because of someone not being able to handle their loss...get out of stocks ...go play bingo....u are not equipped to handle it....
bull
of course they are...to get exposure to an under the radar stock...and we appreciate the fact that you are bring to the forefront the fact that micro caps need all the help they can to get exposure in a market that works against them....we appreciate all you help....so thanks
bull
thanks for the new info mayor.....
bull
GREAT....thanks does that mean the stock is going up....
you guys are talking about 2 different things.....in the U.S.
If it is approved, the patent is granted to the company and will last as long as 20 years from the filing date. Exclusivity to the drug will vary and can last as long as 7 years depending on the type of drug it is.
And companies can file for a drug patent extension...usually extra 5 yrs...
bull
we are trading like any stock should with pullbacks....that's all ...no stock goes straight up...this small priced stock has a lot of day traders on it...as the pps goes up some of them won't be able to afford trading it...they move their pennies to another one..
Here's What Day Traders Don't Understand
"As we explained earlier, day-trading is one of the dumbest jobs there is: According to one academic study, 4 out of 5 people who do it lose money and only 1 in 100 do it well enough to be described as "predictably profitable."
Most of the folks who do it, in other words, would be far better off working at Burger King.
As is often the case when we bring up these facts, some readers screamed. One said that our brain-damage was made patently obvious by the fact that Wall Street professionals day-trade all day. If day-trading were so dumb, then why would professionals do it?
Here's what that particular reader is missing:
Most Wall Street traders get paid to day-trade other people's money.*
That's a huge difference compared to what most stay-at-home day-traders do.
The average professional trader gets paid somewhere between 1% and 3% of assets per year just to trade those assets all day. The average hedge-fund trader gets paid another 20% on top of that for any "gains" he or she makes (regardless of whether the gains are the result of the trader's trading or the bull market).
The average stay-at-home day-trader, meanwhile, trades his or her own money. And while many of these traders do fine on a gross basis (before costs), once the costs of this trading are deducted (commissions, taxes, research and information, time), their performance is usually downright awful.
The reason so many professionals day-trade, in other words, is that getting paid to day-trade other people's money is one of the best businesses in the world.
Day-trading your OWN money, meanwhile, is one of the worst."
bull
for your information I have owned this stock since before they even got involved with mj....and have just held my position...I'm done with the conversation because your comments have not been all over the place since you have been on the mb that I don't know what your intentions are...good luck
bull
I guess you are not understanding we don't care that they are not at that address anymore....now you say you sold last Monday at a loss...take your loss like a man....move on and make your money back somewhere else if you don't feel like it is with this stock...the more you talk the less credible you sound...and if you shorted the stock like I think you did before you started to trash it...I think that was a mistake just like selling for the loss...because the stock is holding it's strong support of .025....it has not closed below that since it closed at .027 on 2/11....almost 2 months...
bull
look at the chart....breakout of the flag pennant..to the upside on strong volume....BULLISH....went from .325 to .45 in 3 days of most heavily shorted days since 2/19..and the stock went up all 3 days...BULLISH...Fri..shorts down..some covering...stock is on it's next leg up...BULLISH...Friday's close was higher than Thursday's open...BULLISH...Parabolic SAR turned up Thursday.....BULLISH...MACD just crossed over on Thursday....BULLISH...shorts know what is coming.....
bull
I agree with you on everything but one thing you said...."The charts show a downward pattern"....what chart are you looking at....look at the daily chart for the last 3 months and tell me that is downward..
bull
see already talking about pump article...he was a soft short basher and now he is a hard one......seen it before many times...
he already sold...he said that....and now you have a disgruntled investor...instead of moving on and making back his loss somewhere he will stay here and do this...get used to it....or ignore it like I will from now on...
bull
Joesph Spadafore has always had office space in Temecula....this is not a huge company....it is a start up...these guys don't even take much salary for their age at 45,000 a yr with no incentives...of course the PR is going to come out of his offices...they even sound like they write the PR's themselves...I think you took a loss for nothing...you scared yourself out of your position...
good luck
bull
LOL ...give us pictures and a phone # and a contact we can ask for ...
Perspective
it took the shorts and sellers 4 WEEKS to take us from .58 to .31........it took the big beautiful longs and a few dumb shorts 3 DAYS to take us from .31 to .45..
bull
Nuvilex chart looking great...holding R3 support nicely....even ARCA can't seem to get their short on....lol
bull
Fibonacci levels....retracements and extensions.....
bull
CHART reworked my fib levels for the new trend.....headed toward .653
bull
all that matters is you're back...these prices will look like a blessing in the months to come...if I was not fully vested I would be buying more...I sold several stocks to add to Nuvilex and I want to retain my other bio's....but boy is it tempting ...
good luck
bull
I guess it is working then...because I see 3.3 million longs stepping in this morning....
bull